...
MIRMMID

Mirum Pharmaceuticals, Inc.

HealthcareBiotechnology
$92.29
$0.00(+0.11%)
52W$36.88
$109.28
FinancialsValuationvs AGIO
Updated Mar 1, 12:00 AM
RSI38
RS Rating85/99
Beta0.71
Volatility43%
F-Score6/9
Mkt Cap$4.8B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Mirum Pharmaceuticals, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is leading (RS Rating: 85), indicating clear outperformance against the broad market. Earnings growth of 76% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
85
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.71
vs S&P 500
DEFENSIVE
52W Position
77%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$92.54
50 SMA > 100 SMA$81.51
100 SMA > 150 SMA$77.19
150 SMA > 200 SMA$70.10

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$102.34-9.82%BELOW
50 SMA$92.54-0.27%BELOW
100 SMA$81.51+13.22%ABOVE
150 SMA$77.19+19.56%ABOVE
200 SMA$70.10+31.66%ABOVE

Price Performance

1D+0.1%
1W-12.8%
1M-8.5%
3M+26.3%
6M+22.2%
YTD+18.2%
1Y+94.0%
3Y+57.7%
52-Week Trading Range77% from low
$92.29
52W Low$36.88
52W High$109.28

Technical Indicators

RSI (14)BEARISH
38.4
305070
VCP ScoreCOOL
4/10
Base depth: 49.9%

Risk Profile

Beta
0.71
52W Vol
43%
ATR
$4.16
Max DD (1Y)
-20%

Volume Analysis

Today
92
50D Avg
623.4K
Vol Ratio
0.00x
Liquidity
MODERATE

Earnings Momentum

Q1'25+44%
$-0.30
Q2'25+77%
$-0.12
Q3'25+117%
$0.05
Q4'25+76%
$-0.12
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:—
5 Years:—
3 Years:+89.13%
TTM:+54.74%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:+73.57%

Stock Price CAGR

10 Years:+21.46%
5 Years:+37.94%
3 Years:+57.75%
1 Year:+94.01%

Return on Equity

10Y Avg:-63.7%
5Y Avg:-58.1%
3Y Avg:-43.1%
Last Year:-7.4%

Key Metrics

Market Cap$4.8B
Gross Margin80.8%
Net Margin-4.5%
Piotroski F-Score6/9

More MIRM Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

MIRM vs AGIOAGIOVRTXASNDBBIO

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 85 meansMIRM outperformed 85% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.71 means 29% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 6/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 4/10 with COOL status.

Frequently Asked Questions

Is MIRM in an uptrend right now?

MIRM has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is MIRM overbought or oversold?

MIRM's RSI (14) is 38. The stock is in neutral territory, neither overbought nor oversold.

Is MIRM outperforming the market?

MIRM has a Relative Strength (RS) Rating of 85 out of 99. Yes, MIRM is a market leader, outperforming 85% of all stocks over the past 12 months.

Where is MIRM in its 52-week range?

MIRM is trading at $92.29, which is 84% of its 52-week high ($109.28) and 77% above its 52-week low ($36.88).

How volatile is MIRM?

MIRM has a Beta of 0.71 and 52-week volatility of 43%. It's less volatile than the S&P 500 - generally more stable.